Ramzy I et al. |
GENETIC MUTATIONS AFFECTING THE FIRST LINE ERADICATION THERAPY OF Helicobacter pylori-INFECTED EGYPTIAN PATIENTS. |
2016 |
Rev. Inst. Med. Trop. Sao Paulo |
pmid:27982354
|
Gbinigie II and Lasserson D |
Clarithromycin-induced akathisia: a class effect of macrolides? |
2016 |
BMJ Case Rep |
pmid:27927708
|
Kasai C et al. |
Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection. |
2016 |
BMC Gastroenterol |
pmid:27716077
|
Noda H et al. |
A Novel Potassium-Competitive Acid Blocker Improves the Efficacy of Clarithromycin-containing 7-day Triple Therapy against Helicobacter pylori. |
2016 |
J Gastrointestin Liver Dis |
pmid:27689190
|
Giorgio F et al. |
Helicobacter pylori DNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis. |
2016 |
Scand. J. Gastroenterol. |
pmid:27687850
|
Donzelli A |
Helicobacter pylori Eradication? |
2016 |
Gastroenterology |
pmid:27590693
|
Sanches BS et al. |
Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national survey. |
2016 |
World J. Gastroenterol. |
pmid:27672279
|
Yamamoto K et al. |
Clarithromycin prevents human respiratory syncytial virus-induced airway epithelial responses by modulating activation of interferon regulatory factor-3. |
2016 |
Pharmacol. Res. |
pmid:27468646
|
Ferro BE et al. |
Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27458221
|
Patton PH et al. |
Anti-tuberculous therapy for maintenance of remission in Crohn's disease. |
2016 |
Cochrane Database Syst Rev |
pmid:27444319
|
Christl I et al. |
Clarithromycin and Tetracycline Binding to Soil Humic Acid in the Absence and Presence of Calcium. |
2016 |
Environ. Sci. Technol. |
pmid:27438991
|
Luo XF et al. |
Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of Helicobacter pylori. |
2016 |
World J. Gastroenterol. |
pmid:27433095
|
Sakurai Y et al. |
Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study. |
2016 |
Adv Ther |
pmid:27432383
|
Inagaki K et al. |
Successful Treatment of Peritoneal Dialysis-related Peritonitis due to Mycobacterium iranicum. |
2016 |
Intern. Med. |
pmid:27432106
|
Shiratori S et al. |
Two Cases of Chronic Gastritis with non-Helicobacter pylori Helicobacter Infection. |
2016 |
Intern. Med. |
pmid:27432094
|
Hirasawa K et al. |
Macrolide Antibiotics Exhibit Cytotoxic Effect under Amino Acid-Depleted Culture Condition by Blocking Autophagy Flux in Head and Neck Squamous Cell Carcinoma Cell Lines. |
2016 |
PLoS ONE |
pmid:27977675
|
Mougari F et al. |
Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. |
2016 |
Expert Rev Anti Infect Ther |
pmid:27690688
|
Laird-Fick HS et al. |
Gastric adenocarcinoma: the role of Helicobacter pylori in pathogenesis and prevention efforts. |
2016 |
Postgrad Med J |
pmid:27222587
|
Phiphatpatthamaamphan K et al. |
Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospective Randomized Study. |
2016 |
Asian Pac. J. Cancer Prev. |
pmid:27221874
|
Kim SY et al. |
Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report. |
2016 |
BMC Infect. Dis. |
pmid:27188784
|
Suzuki S et al. |
The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy. |
2016 |
Am. J. Gastroenterol. |
pmid:27185079
|
Xu J et al. |
Preparation, characterization and pharmacokinetics evaluation of clarithromycin-loaded Eudragit(®) L-100 microspheres. |
2016 |
Eur J Drug Metab Pharmacokinet |
pmid:25652786
|
Berende A et al. |
Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease. |
2016 |
N. Engl. J. Med. |
pmid:27028911
|
D'Erme AM et al. |
Successful treatment of rosacea fulminans in a 59-year-old woman with macrolide antibiotics and prednisone. |
2016 |
Int. J. Dermatol. |
pmid:27028670
|
Klesiewicz K et al. |
Anti-Helicobacter pylori activity of some newly synthesized derivatives of xanthone. |
2016 |
J. Antibiot. |
pmid:27025351
|
Kawashima K et al. |
Successful eradication of Helicobacter pylori infection with vonoprazan-based triple therapy after failure of PPI-based triple therapy. |
2016 |
Dig Liver Dis |
pmid:27012448
|
Ormeci A et al. |
Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole. |
2016 |
Eur Rev Med Pharmacol Sci |
pmid:27010145
|
Dubini M et al. |
Multiple drug allergy: A case of anaphylaxis to levofloxacin but tolerance to ciprofloxacin. |
2016 |
Ann. Allergy Asthma Immunol. |
pmid:27009438
|
Miyashita N et al. |
Macrolide Therapy for Prevention of Exacerbation in Individuals with Diffuse Aspiration Bronchiolitis. |
2016 |
J Am Geriatr Soc |
pmid:27000351
|
Belz D et al. |
Mycobacterium marinum infection initially diagnosed as metastatic Crohn's disease. |
2016 |
J Eur Acad Dermatol Venereol |
pmid:25510444
|
Niv Y |
Doxycycline in Eradication Therapy of Helicobacter pylori--a Systematic Review and Meta-Analysis. |
2016 |
Digestion |
pmid:26849820
|
Song Z et al. |
Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy. |
2016 |
Dig Liver Dis |
pmid:26847964
|
Vannarath S et al. |
Antibiotic Resistant Pattern of Helicobacter Pylori Infection Based on Molecular Tests in Laos. |
2016 |
Asian Pac. J. Cancer Prev. |
pmid:26838225
|
Miyamoto S et al. |
Analysis of Helicobacter pylori genotypes in clinical gastric wash samples. |
2016 |
Tumour Biol. |
pmid:26825980
|
Bohnert JA et al. |
Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26824939
|
Gaüzère BA and Malvy D |
[Vingt-cinquième réunion du comité local de la Société de pathologie exotique, 24 novembre 2015]. |
2016 |
Bull Soc Pathol Exot |
pmid:26818816
|
Topp E et al. |
Reduced persistence of the macrolide antibiotics erythromycin, clarithromycin and azithromycin in agricultural soil following several years of exposure in the field. |
2016 |
Sci. Total Environ. |
pmid:27096634
|
Li X et al. |
Macrolides use and the risk of sudden cardiac death. |
2016 |
Expert Rev Anti Infect Ther |
pmid:27086751
|
Konstantinidis T et al. |
Immunomodulatory Role of Clarithromycin in Acinetobacter baumannii Infection via Formation of Neutrophil Extracellular Traps. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26643338
|
Ferro BE et al. |
Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26643335
|
Boyanova L et al. |
Clarithromycin Resistance Mutations in Helicobacter pylori in Association with Virulence Factors and Antibiotic Susceptibility of the Strains. |
2016 |
Microb. Drug Resist. |
pmid:26618567
|
Wu TS et al. |
Postcesarean section wound infection caused by Mycobacterium massiliense. |
2016 |
J Microbiol Immunol Infect |
pmid:26350122
|
Senatore FJ et al. |
Helicobacter pylori treatment: Still a work in progress. |
2016 |
Postgrad Med |
pmid:26490697
|
Shin WG et al. |
Eradication Rates of Helicobacter pylori in Korea Over the Past 10 years and Correlation of the Amount of Antibiotics Use: Nationwide Survey. |
2016 |
Helicobacter |
pmid:26470999
|
Cerqueira RM et al. |
How Effective Is the Quadruple Concomitant Helicobacter Pylori Eradication Therapy for Obese Patients Undergoing Gastric Bypass Surgery? |
2016 |
Obes Surg |
pmid:26467690
|
Boyanova L et al. |
Helicobacter pylori resistance to six antibiotics by two breakpoint systems and resistance evolution in Bulgaria. |
2016 |
Infect Dis (Lond) |
pmid:26465202
|
Narita M et al. |
Antimicrobial Susceptibility of Microorganisms Isolated from Periapical Periodontitis Lesions. |
2016 |
Bull. Tokyo Dent. Coll. |
pmid:27665691
|
Ghaith D et al. |
Mutations affecting domain V of the 23S rRNA gene in Helicobacter pylori from Cairo, Egypt. |
2016 |
J Chemother |
pmid:26358218
|
Yoon H et al. |
Effects of N-acetylcysteine on First-Line Sequential Therapy for Helicobacter pylori Infection: A Randomized Controlled Pilot Trial. |
2016 |
Gut Liver |
pmid:26347514
|
Liou JM et al. |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of in the community and hospital populations: a randomised trial. |
2016 |
Gut |
pmid:26338825
|